
© 2024 ARIVA.de
Realtime | Geld | Brief | Zeit |
---|---|---|---|
22,890 | 23,160 | 13:35 | |
22,950 | 23,240 | 13:35 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11.03. | Daiichi taps Nosis to deliver RNA therapies beyond the liver | ||
04.03. | DelveInsight Business Research, LLP: Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight | On February 14, 2025, Ono Pharmaceuticals secured FDA approval for vimseltinib, a therapy for tenosynovial giant cell tumor (TGCT), which will be marketed as ROMVIMZA. This approval places... ► Artikel lesen | |
04.03. | DelveInsight Business Research, LLP: Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight | On February 14, 2025, Ono Pharmaceuticals secured FDA approval for vimseltinib, a therapy for tenosynovial giant cell tumor (TGCT), which will be marketed as ROMVIMZA. This approval places... ► Artikel lesen | |
03.03. | AstraZeneca, Daiichi unblind Enhertu study early as star ADC helps stomach cancer patients live longer | ||
03.03. | Daiichi Sankyo and AstraZeneca report positive result in trial for its gastric cancer treatment |